These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3242 related articles for article (PubMed ID: 7717130)

  • 41. Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data.
    Malaise EP; Fertil B; Chavaudra N; Guichard M
    Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):617-24. PubMed ID: 3009370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. To fractionate or not to fractionate? That is the question for the radiosurgery of hypoxic tumors.
    Toma-Dasu I; Sandström H; Barsoum P; Dasu A
    J Neurosurg; 2014 Dec; 121 Suppl():110-5. PubMed ID: 25434944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiosensitivity of human cell lines to small doses. Are there some clinical implications?
    Malaise EP; Lambin P; Joiner MC
    Radiat Res; 1994 Apr; 138(1 Suppl):S25-7. PubMed ID: 8146319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular Radiosensitivity of Soft Tissue Sarcoma.
    Haas RL; Floot BGJ; Scholten AN; van der Graaf WTA; van Houdt W; Schrage Y; van de Ven M; Bovée JVMG; van Coevorden F; Vens C
    Radiat Res; 2021 Jul; 196(1):23-30. PubMed ID: 33914890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiosurgery and fractionated radiation therapy: comparison of different techniques in an in vivo rat glioma model.
    Kondziolka D; Somaza S; Comey C; Lunsford LD; Claassen D; Pandalai S; Maitz A; Flickinger JC
    J Neurosurg; 1996 Jun; 84(6):1033-8. PubMed ID: 8847568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A challenge to traditional radiation oncology.
    Fowler JF; Tomé WA; Fenwick JD; Mehta MP
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1241-56. PubMed ID: 15519797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of cellular radiation sensitivity on local tumor control of human melanoma xenografts given fractionated radiation treatment.
    Rofstad EK
    Cancer Res; 1991 Sep; 51(17):4609-12. PubMed ID: 1873806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of the hypoxic cell drug SR-4233 alone or combined with the ionizing radiations on two human tumor cell lines having different radiosensitivity.
    Lambin P; Guichard M; Chavaudra N; Malaise EP
    Radiother Oncol; 1992 Jul; 24(3):201-4. PubMed ID: 1410575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Response of human tumor cells of varying radiosensitivity and radiocurability to fractionated irradiation.
    Dahlberg WK; Azzam EI; Yu Y; Little JB
    Cancer Res; 1999 Oct; 59(20):5365-9. PubMed ID: 10537321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
    Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
    BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ovarian cancer: radiation sensitivity in vitro.
    Slotman BJ; Karim AB; Rao BR
    Radiother Oncol; 1990 Dec; 19(4):323-7. PubMed ID: 2284443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?].
    Dunst J; Gebhart E; Neubauer S
    Strahlenther Onkol; 1995 Oct; 171(10):581-6. PubMed ID: 8571177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation.
    Chvetsov AV; Rajendran JG; Zeng J; Patel SA; Bowen SR; Kim EY
    Med Phys; 2017 May; 44(5):1975-1982. PubMed ID: 28236652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinically relevant biomarkers in targeted radiotherapy.
    Stea B; Gordon J
    Clin Exp Metastasis; 2012 Oct; 29(7):853-60. PubMed ID: 22886523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive modeling of hypoxic head and neck cancers during fractionated radiotherapy with gold nanoparticle radiosensitization.
    Huynh M; Kempson I; Bezak E; Phillips W
    Med Phys; 2021 Jun; 48(6):3120-3133. PubMed ID: 33818799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer.
    Willner J; Baier K; Caragiani E; Tschammler A; Flentje M
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):382-9. PubMed ID: 11872283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiobiological modeling of combined targeted 131I therapy and total body irradiation for treatment of disseminated tumors of differing radiosensitivity.
    Amin AE; Wheldon TE; O'Donoghue JA; Barrett A
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):323-30. PubMed ID: 8407407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inherent radiosensitivity and split-dose recovery in plateau-phase cultures of 10 human tumour cell lines.
    Courdi A; Bensadoun RJ; Gioanni J; Caldani C
    Radiother Oncol; 1992 Jun; 24(2):102-7. PubMed ID: 1496140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sublethal damage repair in two radioresistant human tumor cell lines irradiated as multicellular spheroids.
    Schwachöfer JH; Crooijmans RP; Hoogenhout J; Kal HB; Theeuwes AG
    Tumour Biol; 1991; 12(4):207-16. PubMed ID: 1871510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis.
    Clarke JW; Register S; McGregor JM; Grecula JC; Mayr NA; Wang JZ; Li K; Gupta N; Kendra KL; Olencki TE; Cavaliere R; Sarkar A; Lo SS
    Am J Clin Oncol; 2010 Feb; 33(1):70-4. PubMed ID: 19652578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 163.